RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) AS A NOVEL TARGET FOR INHIBITING BREAST CANCER BONE METASTASIS
$114,375FY2011Department of the ArmyDOD
Ohio State University, The, Columbus OH
Investigators
View source on USAspending →RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) AS A NOVEL TARGET FOR INHIBITING BREAST CANCER BONE METASTASIS · GrantIndex